Login
$MRK
$144.82 +$0.36 (0.25%) After hours

$MRK 8-K SEC Filings

Filed On Filing
29 Oct 2026 8-K: Results of Operations and Financial Condition

Sum of quarterly amounts may not equal year-to-date amounts due to rounding.

13 Oct 2026 8-K: Departure/Election of Directors or Officers; Compensation

____________________________________________________________________________

04 Aug 2026 8-K: Results of Operations and Financial Condition

Sum of quarterly amounts may not equal year-to-date amounts due to rounding.

28 May 2026 8-K: Submission of Matters to a Vote of Security Holders

(a) The Annual Meeting of Shareholders of Merck & Co., Inc. (the “Company”) was held on May 26, 2026.

22 May 2026 8-K: Other Events

Pursuant to the unanimous written consent and resolutions (collectively, the “Resolutions”) of the Board of Directors of Merck & Co., Inc. (the “Company”) (i) duly adopted and dated March 14, 2024 and (ii) adopted at a meeting duly calle...

30 Apr 2026 8-K: Results of Operations and Financial Condition

Merck & Co., Inc., Rahway, N.J., USA Announces First-Quarter 2026 Financial Results; Highlights Significant Regulatory Approvals and Clinical Milestones

03 Feb 2026 8-K: Results of Operations and Financial Condition

Sum of quarterly amounts may not equal year-to-date amounts due to rounding.

04 Dec 2025 8-K: Other Events

Pursuant to the unanimous written consent and resolutions (collectively, the “Resolutions”) of the Board of Directors of Merck & Co., Inc. (the “Company”) (i) duly adopted and dated March 14, 2024 and (ii) adopted at a meeting duly calle...

30 Oct 2025 8-K: Results of Operations and Financial Condition

Sum of quarterly amounts may not equal year-to-date amounts due to rounding.

09 Sep 2025 8-K: Other Events

Pursuant to the unanimous written consent and resolutions (collectively, the “Resolutions”) of the Board of Directors of Merck & Co., Inc. (the “Company”) (i) duly adopted and dated March 14, 2024 and (ii) adopted at a meeting duly calle...

29 Jul 2025 8-K: Results of Operations and Financial Condition; Costs Associated with Exit or Disposal Activities

Sum of quarterly amounts may not equal year-to-date amounts due to rounding.

29 May 2025 8-K: Submission of Matters to a Vote of Security Holders

The Annual Meeting of Shareholders of Merck & Co., Inc. (the “Company”) was held on May 27, 2025.

24 Apr 2025 8-K: Results of Operations and Financial Condition

Total Worldwide Sales Were $15.5 Billion, a Decrease of 2% From First Quarter 2024; Excluding the Impact of Foreign Exchange, Sales Grew 1%

04 Feb 2025 8-K: Results of Operations and Financial Condition

Sum of quarterly amounts may not equal year-to-date amounts due to rounding.

22 Nov 2024 8-K: Departure/Election of Directors or Officers; Compensation; Amendments to Articles/Bylaws; Change in Fiscal Year

SECTION 1. Annual Meeting. A meeting of the shareholders of Merck & Co., Inc. (hereinafter referred to as the “Company”) shall be held at such places as may from time to time be designated by the Board of Directors and stated in the noti...

31 Oct 2024 8-K: Results of Operations and Financial Condition

Sum of quarterly amounts may not equal year-to-date amounts due to rounding.

30 Jul 2024 8-K: Results of Operations and Financial Condition

Sum of quarterly amounts may not equal year-to-date amounts due to rounding.

30 May 2024 8-K: Submission of Matters to a Vote of Security Holders; Other Events

Note: This reconciliation and tie shall not, for any purpose, be deemed to be a part of the Indenture.

25 Apr 2024 8-K: Results of Operations and Financial Condition

Sales Reflect Continued Strong Growth in Oncology and Vaccines

20 Feb 2024 8-K: Departure/Election of Directors or Officers; Compensation

(b) On February 15, 2024, Peter C. Wendell gave notice to Merck & Co., Inc. (the “Company”) of his intention to retire from the Board of Directors of the Company (the “Board”) as of the Company’s 2024 Annual Meeting of Shareholders on Ma...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support